April 8–10, 2019 · Berlin

Go to article: Home | Deep BreathGo to article: In this issueGo to article: Scandinavian Health Ltd Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: Hapa Company InsightGo to article: NewsGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: The pharma industry briefingGo to article: Molnar Company InsightGo to article: MolnarGo to article: A costly oversight: the ongoing impact of the valsartan recallGo to article: MedelpharmGo to article: Not so elementary, Watson: the roadblocks for AI in pharmaGo to article: ZenatekGo to article: The Petri dish: telling the story of pharma’s most humble ally Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Exploring the causal link between herpes and Alzheimer’s Go to article: Pfeiffer VacuumGo to article: antiSMASH: on the hunt for new antibioticsGo to article: PfanstiehlGo to article: Tackling consequences of air pollution with drug R&DGo to article: SanofiGo to article: Trends for 2019: from global studies to digital therapeuticsGo to article: EventsGo to article: Next issue